Quest Reports 1 Percent Q4 Sales Dip | GenomeWeb

NEW YORK (GenomeWeb News) – Quest Diagnostics today reported that its fourth quarter sales were down around 1 percent year over year.

The clinical lab and diagnostic information services provider reported revenues of $1.76 billion for the three months ended Dec. 31, 2013, down one percent year over year from $1.77 billion. Analysts, on average, had estimated the firm's revenue for the quarter at around $1.74 billion.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: transcriptional and translational study of human cytomegalovirus interactions with host cells, spider web DNA study, and more.

The New York Stem Cell Foundation signs a lease for a new space.

Researchers gear up for an international meeting to discuss the ethics of gene editing.

In Nucleic Acids Research this week: personal genome approach to RNA-seq read alignment, hematopoietic Systems Biology Repository, and more.